# BeauBrain Healthcare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beaubrain-healthcare

- Industry: Healthcare Specialists
- Headquarters: Seoul, South Korea
- Website: www.beaubrain.bio
- Latest round: Seed (Jul 1, 2022)
- Investors on record: 2

## About

Based in Seoul, South Korea, and founded in 2022 by its CEO Sangwon Seo, and co-founders Na Deok-real, BeauBrain Healthcare operates as a healthcare company that develops brain analysis solutions to diagnose and prevent dementia. In December 2023, BeauBrain Healthcare raised KRW 3 billion in pre-series A funding from Daewoong Pharmaceutical, Lotte Ventures, Tail Ventures, and Korea Technology Finance Corporation. 

BeauBrain Healthcare offers a range of solutions for early prediction of ATN biomarkers (Amyloid Beta, Tau, Neurodegeneration) associated with Alzheimer’s. Additionally, the company provides personalized cognitive training programs (digital therapeutics) designed for prevention and treatment. By amalgamating accumulated ATN biomarker data and cognitive function data with Asia's genetic data, BeauBrain aims to implement precision medicine in its pursuit of freeing individuals from the clutches of dementia.

## Funding rounds

- Seed, Jul 1, 2022 — Korea Tech Incubator for Startup, Infobank

## Investors

- Korea Tech Incubator for Startup — Seed
- Infobank (https://capitalatlas.ai/funds/infobank) — Seed